Tebentafusp, a bispecific protein, consists of a soluble affinity-enhanced T-cell receptor fused to an anti-CD3 effector that can direct T cells to target glycoprotein 100-positive cells.
HLA: human leukocyte antigen; CD3: cluster of differentiation 3.